Fujifilm's factory in Denmark generates USD 430m revenue
Fujifilm Diosynth Biotechnologies, a Japan-based company that produces drugs for other firms, has released its first annual accounting report since it started operating in Denmark. This comes two years after the company bought a medicine factory in the country.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY CATHERINE BRETT
Two years after Fujifilm Diosynth Biotechnologies (FDB) spent DKK 6bn (USD 960m) on a medicine factory in Northern Zealand, Denmark, the contract producer has released its first annual accounting report for its Danish operations.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Fujifilm starts expanding Danish production facility
For subscribers
.jpg)
Danish government cancels vaccine production tender
For subscribers
